Table 1.
Demographics and Psychiatric Treatment Use | Depression/anxiety + ASD (n = 268) | Depression/anxiety only (n = 1,072) |
---|---|---|
Sex | ||
Male | 68.7% | 68.7% |
Female | 31.3% | 31.3% |
Race/Ethnicity | ||
African-American | 7.9% | 7.9% |
Hispanic | 4.1% | 4.1% |
White | 84.3% | 84.3% |
Other | 3.7% | 3.7% |
Mean age | 26.20 | 26.20 |
18–29 years | 76.1% | 76.1% |
30–39 years | 13.1% | 13.1% |
40–49 years | 6.7% | 6.7% |
50–65 years | 4.1% | 4.1% |
Chronic illness 6 month pre-depression/anxiety diagnosis | 4.1% | 2.3% |
Chronic illness during 2009 | 11.9% | 12.6% |
Other comorbid psychiatric disorder | ||
ADHD*** | 10.4% | 3.3% |
Bipolar | 14.9% | 12.9% |
Substance abuse*** | 4.1% | 21.9% |
Schizophrenia | 5.6% | 4.2% |
Intellectual disability*** | 8.2% | .6% |
Other psychiatric disorder** | 28.0% | 20.1% |
Psychotropic medication use among full sample | ||
Antidepressant | 51.1% | 51.6% |
Antipsychotic*** | 39.6% | 21.5% |
Benzodiazepine | 28.0% | 24.2% |
CNS stimulant*** | 11.9% | 6.1% |
Monthly mean number of psychotropic medication use days among users | ||
Antidepressant*** | 24.18 | 16.91 |
Antipsychotic*** | 25.04 | 15.35 |
Benzodiazepine*** | 20.78 | 14.67 |
CNS stimulant* | 23.22 | 18.74 |
Talk therapy use | ||
Individual talk therapy | 73.5% | 72.1% |
Individual talk therapy for anxiety/depression* | 57.1% | 64.3% |
Group therapy* | 0.7% | 2.9% |
Case management*** | 27.2% | 7.7% |
Monthly mean number of talk therapy use among users | ||
Individual talk therapy*** | .64 | .44 |
Individual talk therapy for anxiety/depression | .35 | .37 |
Group therapy | .10 | .28 |
Case management* | .61 | .41 |
Two or more psychotropic medication use** | 47.0% | 36.3% |
Three or more psychotropic medication use* | 20.9% | 15.2% |
Note.
p<.05,
p<.01,
p<.001.
Values in bold font indicate the significantly higher group.